SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS

Circulating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity

Clinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients

Interleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity

Interleukin 17 role as a biomarker in Systemic Lupus Erythematosus patients.

Association between Interleukin-21 Serum Level and IL-21 Genetic Polymorphism with the Cardiovascular Morbidity Risk in Rheumatoid Arthritis and Systemic Lupus Erythematosus Pati

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Interleukin 26 in patients with systemic lupus erythematosus

Serum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity